Tag: Corporate

HAIKOU, China, June 11, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn Hainan province is doubling down on its digital economy, leveraging free trade port...

HAIKOU, China, June 11, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn ...

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

Defiance ETFs to Launch SPCU, The 2X SpaceX ETF, as the SpaceX (SPCX) IPO Nears

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./TORONTO, June 10, 2026 /CNW/ - Canada...

WOODLAND PARK, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2026.

Jiangsu, China, June 10, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (Nasdaq: MTEN) (the “Company”) today announced the closing of its previously announced registered direct offering of 1,131,004 Class A ordinary shares, par value $0.00005 per share (“Class A Ordinary Shares”), at a purchase price of $2.00 per share, and pre-funded warrants to purchase Class A Ordinary Shares at an original exercise price of $2.00, with $1.99995 of the original exercise price pre-funded at the closing, and a remaining exercise price of $0.00005 per Class A Ordinary Share.

CLEVELAND, June 10, 2026 /PRNewswire/ -- CrossCountry Mortgage (CCM), the nation's number one retail mortgage lender for the third consecutive year, welcomes mortgage industry...

NEW YORK, June 10, 2026 /PRNewswire/ -- Executives from New York's major investment banks and law firms packed the Edison Ballroom this past Wednesday...

Alaska Airlines and Microsoft join Twelve to mark commercial operation of AirPlant One — the first plant in the United States to produce E-Jet...

Check Point gains access to GPT-5.5 with Trusted Access for Cyber for high-stakes defensive security operations and dedicated support from OpenAI's cybersecurity teamREDWOOD CITY,...

Amsterdam, June 10, 2026